Anixa Biosciences, Inc.
NASDAQ:ANIX
Overview | Financials
Company Name | Anixa Biosciences, Inc. |
Symbol | ANIX |
Currency | USD |
Price | 3.62 |
Market Cap | 116,489,786 |
Dividend Yield | 0% |
52-week-range | 2.15 - 5.13 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Amit Kumar Ph.D. |
Website | https://www.anixa.com |
An error occurred while fetching data.
About Anixa Biosciences, Inc.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD